Panacea Biotec Limited – NSE:PANACEABIO.NS
Panacea Biotec Limited stock price today
Panacea Biotec Limited stock price monthly change
Panacea Biotec Limited stock price quarterly change
Panacea Biotec Limited stock price yearly change
Panacea Biotec Limited key metrics
Market Cap | 26.28B |
Enterprise value | 7.29B |
P/E | 0.62 |
EV/Sales | 1.54 |
EV/EBITDA | 0.43 |
Price/Sales | 1.57 |
Price/Book | 0.92 |
PEG ratio | N/A |
EPS | -0.17 |
Revenue | 5.59B |
EBITDA | -107.5M |
Income | -10.2M |
Revenue Q/Q | 5.84% |
Revenue Y/Y | 21.57% |
Profit margin | 257.85% |
Oper. margin | -29.04% |
Gross margin | 43.98% |
EBIT margin | -29.04% |
EBITDA margin | -1.92% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePanacea Biotec Limited stock price history
Panacea Biotec Limited stock forecast
Panacea Biotec Limited financial statements
| Jun 2023 | 1.29B | 109.8M | 8.5% |
|---|---|---|---|
| Sep 2023 | 1.43B | -82.9M | -5.8% |
| Dec 2023 | 1.50B | -22.8M | -1.51% |
| Mar 2024 | 1.36B | -14.3M | -1.05% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 12721600000 | 4.28B | 33.71% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 12406800000 | 4.02B | 32.4% |
| Mar 2023 | 190.2M | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 189.6M | 0 | 0 |
| Sep 2023 | 186.2M | 0 | 0 |
| Dec 2023 | 182.2M | 0 | 0 |
Panacea Biotec Limited alternative data
| Aug 2023 | 1,815 |
|---|---|
| Sep 2023 | 1,815 |
| Oct 2023 | 1,794 |
| Nov 2023 | 1,794 |
| Dec 2023 | 1,794 |
| Jan 2024 | 1,794 |
| Feb 2024 | 1,794 |
| Apr 2024 | 1,794 |
| May 2024 | 1,794 |
| Jun 2024 | 1,794 |
| Jul 2024 | 1,794 |
Panacea Biotec Limited other data
| Insider | Compensation |
|---|---|
Mr. Soshil Kumar Jain (1934) Founder & Chairman | $11,200,000 |
Dr. Rajesh Jain Ph.D. (1964) MD & Whole-Time Director | $7,420,000 |
Mr. Sandeep Jain (1966) Joint MD & Executive Director | $6,950,000 |
-
What's the price of Panacea Biotec Limited stock today?
One share of Panacea Biotec Limited stock can currently be purchased for approximately $196.4.
-
When is Panacea Biotec Limited's next earnings date?
Unfortunately, Panacea Biotec Limited's (PANACEABIO.NS) next earnings date is currently unknown.
-
Does Panacea Biotec Limited pay dividends?
No, Panacea Biotec Limited does not pay dividends.
-
How much money does Panacea Biotec Limited make?
Panacea Biotec Limited has a market capitalization of 26.28B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 15.18% to 5.59B US dollars.
-
What is Panacea Biotec Limited's stock symbol?
Panacea Biotec Limited is traded on the NSE under the ticker symbol "PANACEABIO.NS".
-
What is Panacea Biotec Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Panacea Biotec Limited?
Shares of Panacea Biotec Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Panacea Biotec Limited's key executives?
Panacea Biotec Limited's management team includes the following people:
- Mr. Soshil Kumar Jain Founder & Chairman(age: 91, pay: $11,200,000)
- Dr. Rajesh Jain Ph.D. MD & Whole-Time Director(age: 61, pay: $7,420,000)
- Mr. Sandeep Jain Joint MD & Executive Director(age: 59, pay: $6,950,000)
-
Is Panacea Biotec Limited founder-led company?
Yes, Panacea Biotec Limited is a company led by its founder Mr. Soshil Kumar Jain.
-
How many employees does Panacea Biotec Limited have?
As Jul 2024, Panacea Biotec Limited employs 1,794 workers.
-
When Panacea Biotec Limited went public?
Panacea Biotec Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.
-
What is Panacea Biotec Limited's official website?
The official website for Panacea Biotec Limited is panaceabiotec.com.
-
How can i contact Panacea Biotec Limited?
Panacea Biotec Limited can be reached via phone at +91 11 4167 9000.
Panacea Biotec Limited company profile:
Panacea Biotec Limited
panaceabiotec.comNSE
1,936
Biotechnology
Healthcare
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
New Delhi, 110044
:
ISIN: INE922B01023
CUSIP: Y6695F130
